Cancer Proteome and Biomarkers
Proteomics technologies are used for early detection and diagnosis of cancers for the development of novel therapeutic agents. These studies have led to the development of discovering new drugs and targeted therapeutics towards the tumour cells. Detection, prognosis, diagnosis and therapy of breast cancers are now possible with the advancements in the field of proteomics along with the use of mass spectrometry. This discovery leads to personalized therapy for the patients. Proteins expressed or found in the serum, plasma and the tumour cells using the novel methodologies provide a better view of the heterogeneity of the cancers.